A double-blind, placebo-controlled pilot study of galantamine to improve cognitive dysfunction in minimally symptomatic bipolar disorder

S. Nassir Ghaemi, William S. Gilmer, Robert T. Dunn, Robert E. Hanlon, David E. Kemp, Amber D. Bauer, Lyvia Chriki, Megan M. Filkowski, Philip D. Harvey

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'A double-blind, placebo-controlled pilot study of galantamine to improve cognitive dysfunction in minimally symptomatic bipolar disorder'. Together they form a unique fingerprint.

Medicine & Life Sciences